These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23347632)

  • 41. Artemisinin: discovery from the Chinese herbal garden.
    Miller LH; Su X
    Cell; 2011 Sep; 146(6):855-8. PubMed ID: 21907397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Artemisinin-Resistant Plasmodium falciparum in Africa.
    Lu F; Culleton R; Cao J
    N Engl J Med; 2017 Jul; 377(3):306. PubMed ID: 28723328
    [No Abstract]   [Full Text] [Related]  

  • 43. Combination therapies for malaria are failing--what next?
    Saunders D; Lon C
    Lancet Infect Dis; 2016 Mar; 16(3):274-5. PubMed ID: 26774241
    [No Abstract]   [Full Text] [Related]  

  • 44. Is chloroquine making a comeback?
    Hand CC; Meshnick SR
    J Infect Dis; 2011 Jan; 203(1):11-2. PubMed ID: 21148490
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence of a hard selective sweep for artemisinin resistant Plasmodium falciparum.
    Hemming-Schroeder E; Lo E
    Lancet Infect Dis; 2017 May; 17(5):462-463. PubMed ID: 28161568
    [No Abstract]   [Full Text] [Related]  

  • 46. Artemisinin-Resistant Plasmodium falciparum in Africa.
    Rasmussen C; Nyunt MM; Ringwald P
    N Engl J Med; 2017 Jul; 377(3):305-306. PubMed ID: 28723327
    [No Abstract]   [Full Text] [Related]  

  • 47. Parasite clearance after malaria therapy: staying a step ahead of drug resistance.
    Karunajeewa HA
    BMC Med; 2015 Oct; 13():251. PubMed ID: 26429335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In vitro interaction studies of azithromycin and dihydroartemisinin in Plasmodium falciparum isolates from Bangladesh].
    Vossen MG; Haque R; Starzengruber P; Khan WA; Thriemer K; Marma AS; Akther S; Fukuda M; Noedl H
    Wien Klin Wochenschr; 2007; 119(19-20 Suppl 3):71-5. PubMed ID: 17987362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artemisinin nanoformulation suitable for intravenous injection: Preparation, characterization and antimalarial activities.
    Ibrahim N; Ibrahim H; Sabater AM; Mazier D; Valentin A; Nepveu F
    Int J Pharm; 2015 Nov; 495(2):671-9. PubMed ID: 26383839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Watching the availability and use of rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT).
    Steketee RW; Eisele TP
    Malar J; 2017 Apr; 16(1):165. PubMed ID: 28434397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artemisinin Resistance and the Blame Game.
    Krishna S; Staines HM; Kremsner PG
    Clin Infect Dis; 2016 Oct; 63(8):1144-5. PubMed ID: 27461919
    [No Abstract]   [Full Text] [Related]  

  • 52. Artemisinin Resistance in Southeast Asia.
    Meshnick S
    Clin Infect Dis; 2016 Dec; 63(11):1527. PubMed ID: 27553373
    [No Abstract]   [Full Text] [Related]  

  • 53. Encapsulation of metalloporphyrins and falciparum malaria.
    Wiwanitkit S; Wiwanitkit V
    Nanomedicine; 2015 May; 11(4):1035. PubMed ID: 25678198
    [No Abstract]   [Full Text] [Related]  

  • 54. The Importance of Scientific Debate in the Identification, Containment, and Control of Artemisinin Resistance.
    Hastings IM; Kay K; Hodel EM
    Clin Infect Dis; 2016 Dec; 63(11):1527-1528. PubMed ID: 27558565
    [No Abstract]   [Full Text] [Related]  

  • 55. REPLY to Nanomedicine: NMB, 2015; 11:1035.
    Alves E; Iglesias B; Deda D; Budu A; Matias T; Bueno V; Maluf F; Guido R; Oliva G; Catalani L; Araki K; da Silva Garcia CR
    Nanomedicine; 2015 May; 11(4):1036-7. PubMed ID: 25678197
    [No Abstract]   [Full Text] [Related]  

  • 56. How worthwhile is methylene blue as a treatment of malaria?
    Müller O; Lu G; Jahn A; Mockenhaupt FP
    Expert Rev Anti Infect Ther; 2019 Jul; 17(7):471-473. PubMed ID: 31237457
    [No Abstract]   [Full Text] [Related]  

  • 57. Artemisinin combination therapy: a good antimalarial, but is the dose right?
    Garner P
    PLoS Med; 2013 Dec; 10(12):e1001565. PubMed ID: 24348204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triple artemisinin-based combination therapies for malaria: proceed with caution.
    Wang J; Xu C; Wong YK; Ma N; Liao FL; Jiang T; Tu Y
    Lancet; 2021 Dec; 396(10267):1976. PubMed ID: 33341138
    [No Abstract]   [Full Text] [Related]  

  • 59. A Temporizing Solution to "Artemisinin Resistance".
    Chan XS; White NJ; Hien TT
    N Engl J Med; 2019 Sep; 381(10):989-990. PubMed ID: 31483979
    [No Abstract]   [Full Text] [Related]  

  • 60. A Temporizing Solution to "Artemisinin Resistance". Reply.
    Wang J; Krishna S; Xu C
    N Engl J Med; 2019 Sep; 381(10):990. PubMed ID: 31483980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.